Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPACT-CAD: Pitavastatin vs Atorvastatin in CAD
NCT00861861Phase 4Completed
- Sponsor
- Kumamoto University
- Start
- Sep 2008
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pitavastatin in hypercholesterolemia and coronary artery disease (CAD) (2 arms), sponsored by Kumamoto University. Primary endpoints: HDL-cholesterol at 30 months, Adiponectin at 30 months and 1 more. Started Sep 2008; status: completed.
02
Drugs
pitavastatin
03
Conditions
hypercholesterolemiacoronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00861861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00861861.